Clinical Use of Tamiflu (Oseltamivir)

Journal of the Korean Medical Association

Volumn 51, Issue 8, 2008, Pages 757-763

  Mee, Soo Chang ^a   Jun, Hee Woo ^b  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Avian influenza; Influenza; Oseltamivir

Indexed keywords

EID: 79953202881     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2008.51.8.757     Document Type: Article

References (16)

1. Korean Medical Association/ Korean Academy of Medical Sciences Material for Media. Avian Influenza (Al) Recommendations for People May 8,2008.
2. The Korean Society of Infectious Diseases. Infectious Diseases. Seoul: Koonja Publishing, 2007.
3. Moscona A. Medical management of Influenza infection Annu Rev Med 2008; 59:397-413.
4. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY; Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005;353:1374-1385.
5. Writing committee of the second world health organization consultation on clinical aspects of human infection with avian influenza A(H5N1) virus. Update of avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358: 261-273.
6. Woo JH. Pneumonia and Clinical Understanding Ulsan UUP 1998.
7. World Health Organization. Influenza pandemic preparedness plan. The role of WHO and guidelines for national and regional planning. Geneva, Switzerland Aprill 1999.
8. Cheong HJ. Avian Influenza. J Korean Med Assoc 2005; 48: 1195-1205.
9. Eric De Clercq. Antiviral agents active against influenza A viruses. Nature reviews 2006; 5:1015-1025.
10. Moscona A. Neuraminidase Inhibitors for Influenza. N Engl J Med 2005; 353:1363-1373. (Pubitemid 41362704)
11. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006; 50: 2395-2402. (Pubitemid 43993177)
12. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten R, Xu X, Bright R, Butler E, Wallis TR, Klimov Al, Gubareva LV. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide in 2004-2008. Antimicrob Agents Chemother 2008 Jul 14. (Epub ahead of print)
13. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza, N Engl J Med 1999; 341:1336-1343. (Pubitemid 29503572)
14. Couch RB. Prevention and treatment of influenza. N Engl J Med 2000; 343:1787.
15. Centers for Disease Control and Prevention: Prevention and control of influenza. MMWR Recomm Rep 2007; 56 (RR-6).
16. Whitley RJ. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol 2007; 3:755-767. (Pubitemid 351320642)